Nursing · Research topic

Open research questions in Fatty Acid Research and Health

90 unresolved questions extracted from the limitations and future-work sections of 430 Fatty Acid Research and Health papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • bioavailability is limited by the source, formulation form, and dietary environment - monotherapy has a limited effect - individual differences in metabolic regulation

    Omega-3 fatty acids: multi-target mechanisms and therapeutic applications in neurodevelopmental disorders and epilepsy · 2025 · DOI
  • prioritize precision nutrition approaches - develop innovative functional foods to improve intake efficiency - establish the precise role of Omega-3 fatty acids PUFAs in ADHD treatment

    Omega-3 fatty acids: multi-target mechanisms and therapeutic applications in neurodevelopmental disorders and epilepsy · 2025 · DOI
  • The study faces challenges in terms of inconsistent findings regarding the effects of Omega-3 fatty acids on prostate cancer. The study needs to account for potential confounding factors, such as age, race, and family history, when estimating the hazard ratios for the association between Omega-3 intake and prostate cancer risk.

    Dietary Omega-3 intake may slow prostate cancer progression and reduce mortality risk: evidence from prostate, lung, colorectal, and ovarian cancer screening trial · 2025 · DOI
  • discrepancies in study designs, - variability in individual responses, - the necessity of further research to establish uniform, standardized guidelines

    Omega-3 Polyunsaturated Fatty Acids in Depression · 2024 · DOI
  • The inconsistencies in clinical trial results for omega-3 supplementation in treating depression. The need for further research to establish uniform guidelines for the use of omega-3 fatty acids in managing depressive disorders. The lack of understanding of the potential mechanisms of action of omega-3 fatty acids.

    Omega-3 Polyunsaturated Fatty Acids in Depression · 2024 · DOI
  • However, a series of large-scale randomized controlled trials conducted between 2018 and 2022 produced conflicting results, reigniting debate about the clinical utility of omega-3 supplementation.

    Omega-3 Fatty Acids in the Prevention of Cardiovascular Diseases: Still Relevant? · 2026 · DOI
  • However, ω-3 formulations commonly combine DHA with eicosapentaenoic acid (EPA) in varying proportions, and the impact of the DHA ratio on postsynaptic scaffold regulation remains unclear.

    DHA-dominant Omega-3 compositions enhance PSD-95 organization and glutamatergic protein expression · 2026 · DOI
  • However, epidemiological evidence linking omega-3 intake to the risk of developing osteoporosis is still emerging and remains inconclusive.

    The association between dietary omega-3 intake and osteoporosis: a NHANES cross-sectional study · 2025 · DOI
  • However, existing studies have reported inconsistent findings regarding the effects of Omega-3 fatty acids on prostate cancer, and there is limited large-scale longitudinal data exploring the dose-response relationship.

    Dietary Omega-3 intake may slow prostate cancer progression and reduce mortality risk: evidence from prostate, lung, colorectal, and ovarian cancer screening trial · 2025 · DOI
  • However, since pathophysiological mechanisms are complex and multifactorial, therapeutic strategies remain inconclusive and only provide symptomatic relief to patients.

    Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer’s Disease · 2025 · DOI
  • However, despite established associations between unsaturated fatty acids and chronic diseases, the mechanistic contributions of omega-3 and omega-6 polyunsaturated fatty acids to complex neuropsychiatric disorders remain poorly characterized.

    Mode and Mechanism of Action of Omega-3 and Omega-6 Unsaturated Fatty Acids in Chronic Diseases · 2025 · DOI
  • Omega-3 polyunsaturated fatty acids (PUFAs) exhibit therapeutic potential, yet their molecular mechanisms remain unclear.

    Dietary Omega-3 PUFAs in Metabolic Disease Research: A Decade of Omics-Enabled Insights (2014–2024) · 2025 · DOI
  • The aim of this narrative review is to provide an overview of current knowledge and gaps in the literature regarding MUFAs and the risk of ASCVD with a focus on intake, individual types, and content in adipose tissue as a biomarker of endogenous exposure.

    Monounsaturated Fatty Acids in Cardiovascular Disease: Intake, Individual Types, and Content in Adipose Tissue as a Biomarker of Endogenous Exposure · 2025 · DOI
  • In conclusion, we suggest that future research should focus on individual MUFA types rather than treating them as a homogeneous group, investigate their specific dietary sources and associations with ASCVD risk, and use adipose tissue biomarkers to improve exposure assessment and clarify causal relationships while considering overall dietary patterns.

    Monounsaturated Fatty Acids in Cardiovascular Disease: Intake, Individual Types, and Content in Adipose Tissue as a Biomarker of Endogenous Exposure · 2025 · DOI
  • INTRODUCTION: Although Omega-3 is thought to have anticoagulative properties, the potential untoward effects of Omega-3 during pregnancy have not been investigated.

    Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study · 2024 · DOI
  • Nonetheless, the causal nature of these relationships remains ambiguous due to conflicting findings across studies.

    Polyunsaturated fatty acids and diabetic microvascular complications: a Mendelian randomization study · 2024 · DOI
  • However, research investigating the relationship between ω-3, ω-6 PUFAs, and ω-6 to ω-3 ratio with inflammatory biomarkers remains controversial.

    Associations of ω-3, ω-6 polyunsaturated fatty acids intake and ω-6: ω-3 ratio with systemic immune and inflammatory biomarkers: NHANES 1999-2020 · 2024 · DOI
  • However, previous research has yielded conflicting results, and the association between ω-6 fatty acids, the ω-6: ω-3 ratio, and frailty remains unclear.

    The relationship between dietary intake of ω-3 and ω-6 fatty acids and frailty risk in middle-aged and elderly individuals: a cross-sectional study from NHANES · 2024 · DOI
  • Research on the association between plasma polyunsaturated fatty acids (PUFAs) levels and depression have yielded inconsistent results.

    Association between plasma polyunsaturated fatty acids and depressive among US adults · 2024 · DOI
  • Docosahexaenoic acid (DHA) is well known for promoting visual and brain development, but its effects on early intestinal development remain unknown.

    Maternal docosahexaenoic acid supplementation during lactation improves exercise performance, enhances intestinal glucose absorption and modulates gut microbiota in weaning offspring mice · 2024 · DOI
  • However, the trend towards lower levels of certain lipid mediators in the homozygous ancestral genotype group warrants further investigation to elucidate the underlying mechanisms of different FADS1 genotypes and potential implications for cardiometabolic risk.

    Effect of FADS1 SNPs rs174546, rs174547 and rs174550 on blood fatty acid profiles and plasma free oxylipins · 2024 · DOI
  • Despite these facts, limited information is available on the potential nutritional and anti-arteriolosclerosis effects of chufa oil, olive oil, and anhydrous milk fat in C57BL/6N mice.

    Nutritional and potential health benefits of chufa oil, olive oil, and anhydrous milk fat against gallstone disease in a C57BL/6N mouse model · 2024 · DOI
  • Original investigations into the biological activity of endogenous SPMs led to the pairing of these ligands with the FPR2/LX receptor, and these results have been challenged in more recent work, leading to conflicting results and views, which are again discussed.

    Advances in the Chemistry and Biology of Specialised Pro-Resolving Mediators (SPMs) · 2024 · DOI
  • Conjugated linoleic acid (CLA) has been extensively characterized due to its many biological activities and health benefits, but conjugated linolenic acid (CLnA) is still not well understood.

    Conjugated Linolenic Acid (CLnA) vs Conjugated Linoleic Acid (CLA): A Comprehensive Review of Potential Advantages in Molecular Characteristics, Health Benefits, and Production Techniques · 2024 · DOI
  • Future research should focus more on the advantageous characteristics of different isomers, especially the effectiveness and safety in clinical applications in order to truly exert the potential value of CLnA.

    Conjugated Linolenic Acid (CLnA) vs Conjugated Linoleic Acid (CLA): A Comprehensive Review of Potential Advantages in Molecular Characteristics, Health Benefits, and Production Techniques · 2024 · DOI

Most-cited papers in Fatty Acid Research and Health

Most recent work

Find a gap in your own Fatty Acid Research and Health sub-topic

This page shows what the Fatty Acid Research and Health literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Nursing

90 open questions have been extracted from the limitations and future-work passages of 430 Fatty Acid Research and Health papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.